| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 77041 |
tris-苄基-DOTA tris-benzyl-DOTA |
118 |
h |
2024-12-19 |
| 77042 |
DOTA-DN(PTX)-BN DOTA-铃蟾肽功能化聚酰胺胺(PAMAM)树状大分子(DN)负载紫杉醇 |
106 |
h |
2024-12-19 |
| 77043 |
NH2-Sar10-COOH，ADC定制 |
86 |
wyh |
2024-12-19 |
| 77044 |
cas:1415328-95-8，NHPI-PEG4-C2-NHS ester |
112 |
zyl |
2024-12-19 |
| 77045 |
Gd-GlyMe-DOTA-全氟辛基甘露糖缀合物(Gadofluorine M) |
144 |
h |
2024-12-19 |
| 77046 |
MC-Val-Cit-PAB-PNP（CAS号：159857-81-5） |
125 |
WYQ |
2024-12-19 |
| 77047 |
Mal-Gly-Gly-L-Phe-N-[(carboxymethoxy)methyl]Glycinamide，ADC定制 |
97 |
wyh |
2024-12-19 |
| 77048 |
L-RNA寡核苷酸的功能化DOTA |
113 |
h |
2024-12-19 |
| 77049 |
MA-PEG4-Glu(t-Bu)-Val-Cit-PAB-PNP，在药物递送系统中具有广泛应用潜力 |
93 |
WYQ |
2024-12-19 |
| 77050 |
cas:1415800-42-8，perfluorophenyl 1-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-3,6,9,12-tetraoxapentadecan-15-oate |
80 |
zyl |
2024-12-19 |
| 77051 |
羟基磺基琥珀酰亚胺DOTA(DOTA-OSSu) |
129 |
h |
2024-12-19 |
| 77052 |
Mal-PEG1-Val-Cit-OH，生物化学和药物研发领域有潜在应用 |
94 |
WYQ |
2024-12-19 |
| 77053 |
cas:1193111-39-5，1-(2,5-dioxopyrrolidin-1-yloxy)-1-oxo-4-(pyridin-2-yldisulfanyl)butane-2-sulfonic acid |
88 |
zyl |
2024-12-19 |
| 77054 |
DOTA-GGG-BN(7-14) |
92 |
h |
2024-12-19 |
| 77055 |
CAS: 108-30-5，Dihydrofuran-2,5-dione（丁二酸酐） |
121 |
WYQ |
2024-12-19 |
| 77056 |
cas:1884578-00-0 Boc-Val-Ala-PAB-PNP |
104 |
zyl |
2024-12-19 |
| 77057 |
DOTA-L22-异硫氰酸荧光素-依沙酸 |
88 |
h |
2024-12-19 |
| 77058 |
cas:2768446-73-5 DBCO-Val-Cit-PAB-MMAE |
86 |
zyl |
2024-12-19 |
| 77059 |
Boc-PEG4-Val-Ala-PAB，ADC定制 |
93 |
wyh |
2024-12-19 |
| 77060 |
CAS: 2504147-59-3，MC (C5)-Val-Cit |
81 |
WYQ |
2024-12-19 |
| 77061 |
CAS: 159857-80-4，MC-Val-Cit-PAB-OH |
102 |
WYQ |
2024-12-19 |
| 77062 |
cas:2055024-65-0 Azido-PEG3-Val-Cit-PAB-OH |
93 |
zyl |
2024-12-19 |
| 77063 |
Mal-Amide-PEG4-Val-Cit-PAB-OH，ADC定制 |
77 |
wyh |
2024-12-19 |
| 77064 |
CAS 2249935-92-8：Mal-PEG1-Val-Cit-PAB-PNP |
97 |
WYQ |
2024-12-19 |
| 77065 |
cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
104 |
zyl |
2024-12-19 |
| 77066 |
Alkyne-Val-Cit-PAB-OH，ADC定制 |
136 |
wyh |
2024-12-19 |
| 77067 |
CAS 2395887-69-9：Mal-PEG2-Val-Cit-PAB-PNP |
96 |
WYQ |
2024-12-19 |
| 77068 |
CAS 1438853-35-0：Mal-PEG3-Val-Cit-PAB-PNP |
75 |
WYQ |
2024-12-19 |
| 77069 |
N-(Methyltetrazine-PEG4)-amido-PEG8-3,4-dithiophenolmaleimide |
111 |
zyl |
2024-12-19 |
| 77070 |
MC-beta-Ala-alpha-GlcA-MMAE，ADC定制 |
120 |
wyh |
2024-12-19 |
| 77071 |
Mal-PEG2-Val-Cit-PAB-OH（CAS: 2055041-38-6） |
90 |
WYQ |
2024-12-19 |
| 77072 |
cas:2100306-78-1，t-Butyl 3-(hydroxypropoxyl)-propanoate |
100 |
zyl |
2024-12-19 |
| 77073 |
NHS ester-PEG4-VC-PAB-Daunorubicin，ADC定制 |
104 |
wyh |
2024-12-19 |
| 77074 |
Mal-PEG3-Val-Cit-PAB-OH（CAS: 2727965-49-1） |
119 |
WYQ |
2024-12-19 |
| 77075 |
cas:1539292-60-8，tert-butyl 3-(4-(2-cyanoethynyl)phenylcarbamoyl)propylcarbamate |
76 |
zyl |
2024-12-19 |
| 77076 |
1281816-04-3，Lys-Nε-MCC-DM1，ADC定制 |
75 |
wyh |
2024-12-19 |
| 77077 |
cas:34450-18-5，Alkynyl Stearic Acid，17-十八炔酸 |
136 |
zyl |
2024-12-19 |
| 77078 |
Mal-PEG4-Val-Cit-PAB-OH（CAS: 2055041-39-7） |
125 |
WYQ |
2024-12-19 |
| 77079 |
1281816-04-3，Lys-Nε-MCC-DM1，ADC定制 |
78 |
wyh |
2024-12-19 |
| 77080 |
cas:120550-35-8，Biotin-PFP ester，五氟苯酚生物素酯 |
248 |
zyl |
2024-12-19 |
| 77081 |
MTS-ADO3A 三酸DOTA衍生物 |
120 |
h |
2024-12-19 |
| 77082 |
NHS-PEG2-NH-Xanomeline，ADC定制 |
95 |
wyh |
2024-12-19 |
| 77083 |
DOTA-DAsp-Tyr-Nle-Gly-Trp-Nle-Asp-Phe-NH2 DOTA-CCK |
140 |
h |
2024-12-19 |
| 77084 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
92 |
h |
2024-12-19 |
| 77085 |
cas:2123482-78-8，TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
83 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询